These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3097205)

  • 1. [Long-term observation on the immunogenicity of hepatitis B vaccine in infants and adults].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Shingu T
    Kansenshogaku Zasshi; 1986 Jul; 60(7):659-65. PubMed ID: 3097205
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunogenicity and safety of hepatitis B virus vaccine].
    Hayashi J; Kashiwagi S; Nomura H; Kajiyama W; Ikematsu H; Aoyama T
    Kansenshogaku Zasshi; 1985 Oct; 59(10):970-6. PubMed ID: 3936888
    [No Abstract]   [Full Text] [Related]  

  • 3. [Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses].
    Corbella E; Garghetti L; Poloniato A; Zambelloni C; Consonni A
    Minerva Pediatr; 1987 Oct; 39(20):821-6. PubMed ID: 2963953
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenicity of yeast-derived hepatitis B vaccine in Pakistani adults.
    Zuberi SJ; Lodi TZ; Hassan R; Alam SE
    Indian J Gastroenterol; 1990 Oct; 9(4):291-2. PubMed ID: 2258214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B vaccination in newborn babies.
    Heijtink RA; Weber YA; Mazel JA
    Lancet; 1988 May; 1(8596):1226. PubMed ID: 2897038
    [No Abstract]   [Full Text] [Related]  

  • 6. Hepatitis B immunisation.
    Segal GR
    Med J Aust; 1991 Jan; 154(1):70-1. PubMed ID: 1824604
    [No Abstract]   [Full Text] [Related]  

  • 7. Mass vaccination against hepatitis B in preschool children: immunogenicity after three reduced doses.
    Milne A; Moyes CD; Waldon J; Pearce NE; Krugman S
    N Z Med J; 1989 Aug; 102(874):429-30. PubMed ID: 2527346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term observation for immunogenicity of plasma-derived hepatitis B vaccine and supplementary vaccination of recombinant vaccine in infants].
    Hayashi J; Kashiwagi S; Noguchi A; Ikematsu H; Nomura H; Kajiyama W; Ikeda K; Tamori K; Aoyama T
    Kansenshogaku Zasshi; 1988 Apr; 62(4):349-54. PubMed ID: 3135357
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term observation of the immunogenicity of hepatitis B vaccine in hospital personnel].
    Hayashi J; Kashiwagi S; Ikematsu H; Noguchi A; Ikeda K; Shingu T
    Kansenshogaku Zasshi; 1988 Sep; 62(9):805-10. PubMed ID: 2974059
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis B vaccine in pregnancy: immunogenicity, safety and transfer of antibodies to infants.
    Ayoola EA; Johnson AO
    Int J Gynaecol Obstet; 1987 Aug; 25(4):297-301. PubMed ID: 2887464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity of low-dose intradermal recombinant DNA hepatitis B vaccine.
    Parish DC; Muecke HW; Joiner TA; Pope WT; Hadler SC
    South Med J; 1991 Apr; 84(4):426-30. PubMed ID: 1826567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis B markers in health service personnel with reference to preventive vaccination].
    Stempień R; Małolepsza E; Jabłkowski M; Bielicka G; Górski T
    Pol Tyg Lek; 1988 Jul; 43(29):942-4. PubMed ID: 3237528
    [No Abstract]   [Full Text] [Related]  

  • 13. Immune response to hepatitis B vaccine in subjects positive for serum hepatitis B core antibody alone.
    Wu JS; Tam KM
    Taiwan Yi Xue Hui Za Zhi; 1988 Oct; 87(10):944-7. PubMed ID: 3241153
    [No Abstract]   [Full Text] [Related]  

  • 14. Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results.
    Ayoola EA; Atoba MA; Johnson AO
    Arch Virol; 1986; 91(3-4):291-6. PubMed ID: 2946277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Active pre-exposure immunisation against hepatitis B virus: immunogenicity of hepatitis B vaccine in healthy Thai adults and children.
    Pongpipat D; Suvatte V; Assateerawatts A; Bhethraratt S
    Asian Pac J Allergy Immunol; 1987 Jun; 5(1):63-5. PubMed ID: 2956961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety and immunogenicity of a recombinant hepatitis B vaccine in neonates.
    Gunn TR; Bosley A; Woodfield DG
    N Z Med J; 1989 Jan; 102(860):1-3. PubMed ID: 2521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Duration of the immunoprophylaxis produced by hepatitis B vaccine].
    Hernández JM; Piqueras J; Esteban JI; Esteban R
    Med Clin (Barc); 1985 May; 84(17):714-5. PubMed ID: 4010375
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis B vaccine.
    Drug Ther Bull; 1985 Jul; 23(13):49-51. PubMed ID: 3160568
    [No Abstract]   [Full Text] [Related]  

  • 19. [Active vaccination against hepatitis-B virus infection in thalassemia].
    Goldfarb A; Shouval S; Mani N; Shraga S; Rachmilewitz E
    Harefuah; 1986 Nov; 111(10):273-7. PubMed ID: 2950034
    [No Abstract]   [Full Text] [Related]  

  • 20. [Serologic epidemiology of hepatitis B viral infection and observation on the immunologic effect of hepatitis B vaccine].
    Ge QY
    Zhonghua Yu Fang Yi Xue Za Zhi; 1988 Mar; 22(2):92-4. PubMed ID: 3215090
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.